Active ingredientSivelestatCat. No. P-S052-001CAS 127373-66-4Family · Pharmaceutical analytical standards
Sivelestat
A selective neutrophil elastase inhibitor, launched in Japan in 2002 for acute lung injury associated with systemic inflammatory response syndrome (SIRS). This family brings together the active ingredient, labelled standards and other impurities.
Did you know?The enzyme it blocks, released by white blood cells during inflammation, is called elastase because it can break down elastin, the protein that makes tissues such as the lungs elastic.
Go to the active ingredient →Active ingredientSivelestatCat. No. P-S052-001CAS 127373-66-4
Active ingredientSivelestat Sodium SaltCat. No. P-S052-002CAS 150374-95-1
Isotopically labelledSivelestat-d4Cat. No. P-S052-003
Isotopically labelledSivelestat-d9Cat. No. P-S052-004
ImpuritySivelestat Impurity 1Cat. No. P-S052-005CAS 188114-98-9
ImpuritySivelestat Impurity 2Cat. No. P-S052-006CAS 150374-99-5![Ethyl 2-[(2-aminobenzoyl)amino]acetate](https://img.vitasanlabs.com/vsl-struct/P-S052-007.svg?v=41e934f030)
ImpurityEthyl 2-[(2-aminobenzoyl)amino]acetateCat. No. P-S052-007CAS 5973-34-2
ImpurityOno EI-601Cat. No. P-S052-008CAS 155023-59-9
ImpuritySivelestat Impurity 3Cat. No. P-S052-009CAS 127373-95-9No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.